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for use in diabetes (n = 11; 13%) ), then 7 pain instruments (8%), 5 respiratory question-
naires (6%), 2 urological questionnaires (2%) and 2 treatment specific instruments 
(2%). The remaining 30 (34%) instruments covered individual conditions ranging from 
anaemia to osteoporosis. ConClusions: There are at least 88 patient’s treatment 
satisfaction/preference instruments published for possible use in clinical trials; 31 of 
which are useful for evaluating satisfaction / preference for drug therapies without 
reference to a specific therapy area. For those disease-specific measures, assessment 
of content validity and psychometric properties should be assessed before chosing 
the most appropriate measure for a given study.
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objeCtives: To determine whether dual back-translators improve the transla-
tion process for Patient Report Outcomes (PRO). Methods: Four (4) PROs were 
translated using dual back-translators. The two back-translators worked indepen-
dently, possessing no knowledge of the other’s back-translation. The translated PROs 
were: a physical assessment questionnaire containing 1507 words with medical 
terminology, a physical assessment questionnaire with simple terminology con-
taining 593 words, a COPD questionnaire containing medical concepts with 713 
words, and a cancer treatment questionnaire containing colloquial terminology 
and 403 words. Instances of the following scenario were tallied during analysis: 
one back-translation accurately reflected the source, the other back-translation 
inaccurately reflected the source, but revealed an error in the forward translation. 
The same PROs were analyzed again, focusing only on one of the back-translators 
to compare the number of forward translation revisions that occur when using a 
single back-translator. Results: After analysis, 184 forward translation revisions 
occurred when using dual back-translators. 11 out of the 184 were a revision to a 
forward translation where one back-translation was correct despite the other back-
translation being incorrect. This occurred 4 times amongst Slavic family languages, 
3 times amongst Indian languages, 3 times amongst Southeast Asian languages, and 
once with Chinese. No such revisions occurred amongst Latin and Germanic lan-
guage families. After analysis of the translated PROs with just one back-translator, 
a total of 180 forward translation revisions occurred. ConClusions: A second 
back-translation improves the translation process if the readability of the text of 
higher difficulty, and if Slavic, Asian and Indian language translations are required. 
However, the low number of revisions resulting from one incorrect back-transla-
tion, while using dual back-translators, demonstrates that one back-translator is 
acceptable. Since dual back-translators revealed the need for only 4 more forward 
translation revisions than the single back-translator, the quality output is similar.
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MoBile Phone use in PaTienT RePoRTeD ouTcoMes – a liTeRaTuRe 
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O’Gorman H.
Exco InTouch, Nottingham, UK
objeCtives: To demonstrate the increased use of mobile phones to collect patient 
reported outcomes in research and to show that they are a valid method of data col-
lection. Methods: A literature search was conducted looking at articles published 
between 2009 and 2013 that referenced electronic diaries of some description. Articles 
were pulled out that specifically referenced mobile or cellular phones. Results: 
Twenty-four of out of 157 articles found specifically referenced mobile. The studies 
referenced in these articles were carried out on populations with an age range of 8 
years up to 70 and were split into 12 therapy areas including metabolic and genetic 
disorders, pain, weight management, sexual activity, respiratory and alcohol related. 
Population size ranged from 15 to 994 (mean 145.6; SD-180), and subjects reported 
for a minimum of 7 days (up to 6 reports per day) to a maximum of 365 days (mean 
107.9 days; SD-112.6). Notably, 17 out of the 24 studies allowed the subjects to use 
their own mobile phone for the reporting and 11 referenced smartphones specifi-
cally. ConClusions: All concluded that mobile phones were suited to collect data 
from subjects. It was noted that the use of mobiles was acceptable as they are used 
them in everyday life and found to be convenient; the technology was also inexpen-
sive to implement. The fact that 70.8% of the studies allowed the subjects to use their 
own mobile phones for the reporting emphasises the practicality of using mobile 
phones in patient reported outcomes. Although the mean age of all the studies was 
relatively low, the age range was very wide and researchers can be confident that 
older populations could use mobile phones to collect these data. The rapid adoption 
and technical evolution of mobile technologies and ubiquitous nature show that this 
technology is a valid means to collect patient reported outcomes.
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objeCtives: The lack of empirical and well-accepted cost-effectiveness (CE) thresh-
old is recognized as one of the most important barriers in using Health technology 
assessment (HTA) in policy decisions and this is no exception in Asia Pacific region. 
HTAsiaLink, a network of HTA organizations in Asia has embarked on first collabora-
tive research on determining the CE threshold across 4 countries in Asia Pacific region 
namely Korea, Japan, Malaysia, and Thailand. This pilot study aimed 1)to explore 
the feasibility of the instrument/methods used 2)to examine the value of a quality-
adjusted life-year (QALY) associated with improving quality of life in mild, moderate 
and severe health condition, and extending life during terminal illness. Methods: 
Five EQ-5D health states with different health severity (11121, 11212, 11323, 11223 
objeCtives: There is a variety of disease modifying drugs available for the 
treatment of multiple sclerosis (MS). These drugs are associated with different 
characteristics in key attributes such as side effects, mode of administration etc. 
The current study was carried out to assess the importance of treatment charac-
teristics for patients’ preferences in an ecologically valid design. Methods: In 
a discrete choice experiment (DCE), MS patients from 38 neurological practices 
in Germany (n= 1,153) were asked to choose the most and the least preferred 
drug (best-worst-scaling) among hypothetical multi-attribute alternatives with 
varying levels of the following key attributes: mode of administration, local and 
systemic side effects, frequency of administration, and required monitoring of the 
patient. This design (Case-3, multi-profile case) simulates a real choice situation 
between different hypothetical multi-attribute pharmaceutical treatment alterna-
tives. Results: On average, patients (~75% female) were 42 years of age with 9.6 
years of disease duration, and ~90% reporting prior experience with parenteral 
modes of administration. Count analysis (Flynn & Louviere, 1992; Orme, 2009) 
yielded that mode of administration was the most important attribute guiding 
patients’ preferences, with ‘oral application’ being most desired (selected as best 
option in 63% of the cases). Notably, the studied systemic side effects, such as 
flu-like symptoms or gastrointestinal disorders were only half as important as 
mode of administration for patients’ choice. The second most relevant attribute 
was frequency of administration, with ‘administration once a week’ being the most 
preferred attribute level (in 47% of the cases). ConClusions: Our data indicate 
that for MS patients, the most important attributes of MS disease modifying drugs 
are route of administration (oral being the number one choice by majority) and 
frequency of administration (with intake once a week being the most preferred), 
probably because these aspects meet the patients’ need for low treatment burden 
in daily life.
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objeCtives: Work-loss disability from ailments especially depression become 
shortcoming in economic development thus demands early reverts. No reliable tool 
to evaluate work-loss diability in Thai developed. We assessed reliability and validity 
of Thai version of Lam Employment Absence and Productivity Scale (LEAPS),direct 
patient report outcome subsequent to ailments. Methods: An original LEAPS 
was officially acquired,validated by language experts, distributed to field-test 
from patients age above 18 years with ailments seeking treatment at hospital. The 
scale reliability employed item-scale and inter-item consistency with standardized 
Chronbach’s alpha coefficient. The scale discrimination for patient with income or 
non-income job was determined and compared using area under curve for Receiver 
Operating Characteristics (AuROC) with Chi-square test. Results: There were 
seven main LEAPS items with five responder choices. Of 201 patients, 86(42.8%) 
male,115(57.2%) female, mean (SD)age of 39.6(15.2) years recruited from 3 hospitals. 
132(65.7%) and 69(34.3%) patients were classed in income job and non-income job 
respectively. Background education were graduate 76(38%), vocational certificate 
35(17.5%), high school 42 (21%) and primary education 42(21%). 74 (37.2%) of patients 
had been diagnosed with co-morbidities whom 13(18%) and 61(82%) were psycho-
logical and physical illness respectively. Overall 120(60%) of patients complained 
about their health problems which demanded medical treatment within one week, 
where 58(29%) reported the condition not interfere with daily activities whereas 
36(18%) indicated that the conditions were severe and needed hospitalization. 
The responder to LEAPS was 94.5%. Reliability test for overall internal consistency 
Chronbach’s alpha coefficient were 0.834 with AuROC of 0.78,95%CI:0.72-0.85. The 
AuROC for non-income generating vs income-generating group of 0.82,95%CI:0.71-
0.92 vs 0.77,95%CI:0.69-0.86 were not significant different (p= 0.528) with correspond-
ing Chronbach’s alpha coefficient of 0.811 vs 0.842 (p= 0.667). ConClusions: Thai 
version Lam Employment Absence and Productivity Scale(LEAPS) is reliable to use 
among Thai patients. The scale is robust with consistency among Thai patients with 
employment and loss productivity regardless of income-generating job and highly 
predictive for work-loss disability.
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a sysTeMaTic ReVieW oF PaTienTs’ TReaTMenT saTisFacTion anD/oR 
PReFeRence PaTienT-RePoRTeD oucoMes MeasuRes useD in clinical 
TRials
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objeCtives: To determine the availability of Patient Reported Outcome (PRO) 
instruments measuring Patient’s Treatment Satisfaction and/or Preference for drug 
therapies. Methods: The authors conducted a systematic review of the published 
literature using established biomedical literature databases (Medline and Embase), 
ClinicalTrials.gov as well as a PRO specific database (PROQOLID). The instruments 
identified through the various sources were selected according to specific criteria: 1) 
Include: PRO instruments of Treatment Satisfaction or Preference as a sole concept OR 
PRO instruments with at least two domains of Treatment Satisfaction or Preference; 2) 
Exclude: Evaluation of biomarker control OR No information found on the PRO instru-
ments. Results: The systematic literature review identified a total of 720 articles on 
biomedical databases and 1634 closed clinical trials on Clinicaltrials.gov. The search 
in PROQOLID identified ten PRO instruments. From an initial review, 130 instruments 
were considered of particular relevance. Upon detailed review, 88 PRO instruments 
met selection criteria - nine of which were solely designed for a specific study. Of these 
88 PRO instruments, 31 were generic (35%). The most disease-specific measures were 
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objeCtives: Haemophilia A treatment involves replacement of missing clotting 
factor (FVIII) by intravenous infusion prophylactically or on-demand. Treatment 
adherence is influenced by patients’ beliefs about their condition, treatment and 
side effects; mode of administration can also be a significant barrier. This study 
aimed to assess the psychometric properties of a survey evaluating patient percep-
tion and preference for haemophilia A treatment. Methods: A 40-item survey 
(derived from existing literature) was developed to assess patient perception and 
preference for haemophilia A treatment and delivery systems in five European 
countries. Item refinement and analyses involved: 1) item response and dimen-
sionality analyses using classical test theory; 2) finalisation of items based on data 
analysis and clinical relevance; 3) scoring development; 4) psychometric testing of 
the resulting scores including 4a) Rasch analysis, factor analysis, item-level discri-
minant validity tests and item response distributions; 4b) internal consistency reli-
ability; and 4c) known-groups validity. Results: A total of 273 male patients with 
haemophilia A completed the survey. The results support the survey’s construct, 
known-groups; item-level convergent and divergent validity; and internal consist-
ency reliability. A five-factor solution was observed with the following subscales: 1) 
Ease of using clotting factor treatment; 2) Impact of clotting factor treatment; 3) Risk 
associated with clotting factor treatment; 4) Burden of clotting factor treatment; and 
5) Influence of others on treatment choices. Twenty-seven items were deleted based 
on redundancy identified through poor psychometric performance and low clinical 
relevance, and one item was added (to provide a rating on ease of use of treatment 
which was considered missing from a content validity perspective) resulting in a 
14-item scale. ConClusions: A sequential process of item evaluation and reduc-
tion resulted in a short, patient-completed ‘Perceptions of clotting factor treatment’ 
survey - a brief, psychometrically tested method assessing patient perceptions and 
preference for clotting factor treatment in haemophilia A.
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objeCtives: The Multiple Sclerosis International Quality of Life Questionnaire 
(MusiQoL) has been validated in paper and pencil form. Validating patient-reported 
outcomes using Item Response Theory (IRT) along with Classical Test Theory (CCT) 
methods are becoming progressively more common. The current study examined 
the psychometric properties of the MusiQoL among patients diagnosed with multi-
ple sclerosis (MS) using an online version of the instrument. Methods: Data were 
used from a 2012 US survey of patients self-reporting a diagnosis of MS (N= 1,000). 
The online survey collected information on patients’ demographics, disease and 
treatment history, and health outcomes. Participants also completed the Multiple 
Sclerosis Rating Scale Revised (MSRS-R) and the abbreviated Treatment Satisfaction 
Questionnaire for Medication (TSQM-9). Internal consistency and concurrent valid-
ity were examined for the domain-specific scores and the composite total score 
of the MusiQoL. IRT (one and two-parameter graded response models) analyses 
evaluated item discrimination and item difficulty. Results: Among 1000 patients 
with MS, 82.8% were female, the mean age was 48.7 (SD = 11.29), and 76.7% were 
currently using a disease-modifying medication. Internal consistency (Cronbach’s 
α ) of the total scale of the MusiQoL was 0.913 and the domain scores ranged from 
0.824 to 0.944. The total score of the MusiQoL were moderately-to-strongly correlated 
with MSRS-R (r= -0.551), and adequately correlated with the subscales of the TSQM-9 
(r= 0.138 to 0.348). Items varied in their discrimination (range: 1.507 to 4.814) and dif-
ficulty (range: -2.875 to 2.362) parameters. Majority of the MusiQoL domains best dis-
criminated at lower levels of health-related quality of life (HRQoL). ConClusions: 
IRT and CCT are both helpful means for evaluating the psychometric properties 
of the MusiQoL. The MusiQoL in electronic form is reliable and valid for evaluat-
ing HRQoL in patients with MS, but performs best when discriminating among 
respondents with poorer HRQoL.
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FuncTional oBseRVaTion WiTh TTo in chRonic Diseases
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objeCtives: Ageing population will result in an increased social burden of 
chronic diseases. Therefore we evaluate the impact of three chronic diseases 
(Diabetes Mellitus;DM, Hypertension;HT, Rheumatoid Arthritis;RA) on quality of 
life (QoL) in Hungary with EuroQoL-5D-3L (EQ-5D) EuroQoL-Visual Analogue Scale 
(EQ-VAS) and Time Trade Off (TTO). TTO is useful in health planning, economic 
evaluation as it is a utility measure when health state is based on the willingness 
to trade off lifetime Methods: A total of 468 patients were interviewed with 
EQ-5D, EQ-VAS and TTO. 253 patients with RA, 110 patients with DM and 105 
patients with hypertension filled out the questionnaires. In TTO patients need to 
choose between two alternatives: living with the actual health state for ten years 
or living with perfect health state for Y years. We used the ping-pong method 
to find the minimum Z period of time which is offered in exchange for perfect 
health. Results: The EQ-5D mean scores were according to our expectations: RA 
had lowest (0,525;SD:0,32); DM had 0,73;SD:0,26 and HT had highest (0,769;SD:0,26). 
In contrast TTO was lowest in DM (0,74;SD:0,24); RA was 0,769;SD:0,21 and HT was 
0,815;SD:0,21. TTO results are higher than EQ-5D index scores in all disorders. 
Moderate correlation (0.2< r< 0.7) was observed in all cases between EQ-5D, VAS 
and TTO at 0.01 significance-level opposed to HT where correlation was lower 
(r= 0,18). ConClusions: The low correlation between EQ-5D and TTO in HT could 
be due to the lacking disease awareness in many subjects, TTO needs special con-
sideration in such patients. TTO is an easy method to use but some of the patient 
could not understand the question or they had difficulties to accept the concept 
of giving up life-years, some needed longer explanation. The answer on the EQ-5D 
depend only on patient’s health state however the answer of the TTO depend on 
health, social state and religion.
and 22332) were used. For improving quality of life scenarios, willingness-to-pay 
(WTP) to avoid being in the given health state for a given duration was determined 
to ensure the similar magnitude of QALY gained (0.2 and 0.4QALYs) across health 
conditions. Similarly, in extending life during terminal illness and life saving sce-
narios, WTP for increasing life expectancy for given 0.2 and 0.4QALYs were examined. 
Data were analysed using Predictive Analytics Software (PASW v18.0). Results: The 
mean WTP/QALY value for 199 adult was estimated at MYR10,505 (SD:17311) for mild, 
MYR10,906 (SD:15,101) for moderate and MYR14,981 (SD:21,774) for severe health con-
dition. For terminal illness with extended life scenario, it was estimated at MYR19,611 
(SD:27,054). Participants took mean of 29.74 minutes (SD:6.77) to response. One-third 
(32.2%) of the respondents felt the questionnaire was difficult to answer and 7% rated 
it as very difficult. ConClusions: The instrument used was feasible for determin-
ing the value of WTP/QALY. However, further revision of the questionnaire may be 
required to simplify the research task. This study also suggested that the threshold 
for Malaysia to be MYR10,505(0.35GDP)–MYR19,611(0.66GDP) per QALY.
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objeCtives: In recent years there has been an increase in interest surrounding the 
adaptation of traditional paper-based PRO measures to create ‘ePRO’ (electronic PRO) 
versions. Questionnaires in this format are intended to be administered to patients 
via a tablet or PDA device, website or other electronic media. In collaboration with 
Isis Outcomes, PharmaQuest Ltd. has managed a series of ePRO migration and trans-
lation studies. The aim of the study presented here was to produce versions of the 
Oxford Hip Score (OHS) and Oxford Knee Score (OKS) that can easily be completed 
by patients through electronic media, and that are conceptually equivalent to the 
original paper-based measures. Methods: The adaptation process consisted of 3 
main steps. Firstly a draft ePRO version was produced and discussed to resolve any 
formatting issues. The draft was then tested for conceptual equivalence with the 
paper-based measure via cognitive debriefing interviews with patients from the 
target population. Finally, a series of usability questions were used to assess the 
patients’ experience of completing the ePRO measure. Results: Overall, no com-
prehension issues were reported during the cognitive debriefing step for these ques-
tionnaires, although the clarity of some instructions was questioned. The feedback 
from usability testing varied predominantly by age group, with older respondents 
generally reporting more difficulty in using the ePRO device. However, a large major-
ity of respondents reported that the ePRO version was preferable to a paper ques-
tionnaire. ConClusions: Cognitive debriefing feedback confirmed that the ePRO 
versions presented here were conceptually equivalent to the paper questionnaires. 
The ePRO versions were generally well received by patients, although the usability 
testing highlighted the importance of clear instructions and intuitive software.
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objeCtives: Clinical Outcomes Assessments (COAs) frequently include questions 
to assess patients’ ability to perform specific activities. Some activities may not be 
applicable in the target country, necessitating adaptation during translation. When 
requiring adaptation, a tendency exists to substitute an equally recognizable, but 
non-equivalent, activity. Consideration of movements and exertion, as well as cul-
tural appropriateness, is imperative. Failure to do so can impede data pooling across 
languages in multinational trials. Methods: Languages observed were Eastern 
European, Indian, Middle Eastern, Asian, and Southeast Asian, all of which presented 
difficulties in adapting “Western” activities. The activities analyzed appeared in 
actual patient questionnaires that underwent linguistic validation. Alternatives 
were recommended by linguists and cognitive debriefing subjects. Results: In 
Arabic for Egypt, “bocce” was deemed inapplicable. “Billiards” was suggested as an 
appropriate alternative as both require standing and light exertion. “Bocce” also 
posed difficulties for Indian languages. The initial alternative was “cricket,” however, 
cricket requires higher exertion and running. A suitable alternative was “playing 
marbles,” as the Indian version requires standing, light movement, and no running. 
Questionnaires also may assess one’s ability to complete personal hygiene tasks, 
such as “getting in and out of a bathtub.” In Indian languages, cognitive debriefing 
subjects did not understand “bathtub,” as a majority of the target sample do not have 
“bathtubs” at home. A suitable alternative was “to sit on and get up from a small 
stool in order to take a bath with a tumbler.” This activity replicated both the source 
movement and exertion with a culturally appropriate activity. ConClusions: 
Adaptation of Western activities in COAs requires consideration of the movement 
and exertion involved in the source, as well as maintaining cultural appropriate-
ness and familiarity to the respondent. This is essential when creating a localized 
questionnaire that will yield sound data across languages.
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